Rhabdoid Tumor
Oncology·MeSH: Rhabdoid Tumor
Prevalence
0.1 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Tiragolumab | ENANTA PHARMACEUTICALS INC (ENTA) |
Frequently asked questions
How many drugs are in development for Rhabdoid Tumor?
BioSniper tracks 1 drug in development for Rhabdoid Tumor across 1 company.
How many clinical trials target Rhabdoid Tumor?
There are 1 clinical trial targeting Rhabdoid Tumor tracked by BioSniper.
What is the prevalence of Rhabdoid Tumor?
The estimated prevalence of Rhabdoid Tumor is approximately 0.1 per 100,000 population.
Deep-dive into Rhabdoid Tumor
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis